Eni SpA vs Teladoc Health Inc — how do they compare? Eni SpA trades at $56 (market cap $79.81B), while Teladoc Health Inc trades at $5.77 (market cap $1.01B). The key difference: Eni SpA is far larger — about 79× Teladoc Health Inc's market cap, and Eni SpA pays a 4.39% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Eni SpA for 53 Days and Teladoc Health Inc for 39 Days on average.
| E | TDOC | |
|---|---|---|
Market Cap | $79.81B | $1.01B |
Volume | 365,912 | 4,668,477 |
Sector | Energy | Health |
52-Week High | $57.61 | $9.72 |
52-Week Low | $34.03 | $4.47 |
Typical Hold Time | 53 Days | 39 Days |
Enterprise Value | $104.34B | $1.27B |
Dividend Yield | 4.39% | — |
Signals from Pluang's Aura AI — not financial advice
Eni (E) trades at $56.00, up 3.78% with bullish technical signals from moving averages. The company shows stable cash flow generation despite revenue declines from $132.5B in 2022 to $82.2B in 2025. Recent developments include expansion into humanoid robotics and fuel discount initiatives. Valuation appears attractive with P/E of 12.87 and EV/EBITDA of 4.18, while analyst consensus leans neutral with 61.53% hold ratings.
The stock presents value opportunity with strong cash flows and dividend yield, but faces headwinds from volatile energy markets and recent earnings misses. Upside potential exists from new exploration projects in Venezuela and Indonesia, though execution risks and energy price sensitivity remain key considerations for investors.
Teladoc Health (TDOC) trades at $5.54, down 0.36% on the day, as the stock faces bearish technical momentum despite recent earnings beats. The company maintains strong revenue around $2.5B annually but continues to report net losses, with a -7.13% net income margin in 2026. Analyst sentiment is mixed with 35.7% buy ratings but a consensus price target of $8.83 suggesting 59% upside potential. Recent CFO appointment and legal officer transitions signal management changes amid ongoing operational challenges.
TDOC presents a high-risk opportunity with significant valuation discount (P/S 0.4x) but faces persistent profitability challenges. The integrated care business shows promise with improving margins, while BetterHelp weakness and negative cash flow in 2025 raise concerns. Upside depends on successful execution of turnaround strategy and achieving sustainable profitability in the competitive telehealth market.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Eni is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, the company produced 0.8 million barrels of liquids and 4.6 billion cubic feet of natural gas per day. At end-2021, Eni held reserves of 6.6 billion barrels of oil equivalent, 49% of which are liquids. The Italian government owns a 30.1% stake in the company. Eni is placing its renewable and low-carbon business in a separate entity, Plentitude
Read more on E →Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →